Professor Donna K. Hathaway of The University of Tennessee Health Science Center Receives $2.5 Million Grant for Kidney Transplant Medication Research

Dr. Donna Hathaway

Donna K. Hathaway, PhD, RN, FAAN, University Distinguished Professor in the Department of Advanced Practice and Doctoral Studies in the College of Nursing at the University of Tennessee Health Science Center (UTHSC), has received a grant totaling $2,507,759 from the National Institute of Diabetes and Digestive and Kidney Diseases, a subsidiary of the National Institutes of Health. The award will be used to support a project titled, “An RCT for Medication Adherence in Kidney Transplant Recipients.” The award will be distributed over a four-year period. [Read more...]

UTHSC Assistant Professor Kazuko Sakata, PhD, Receives $147,500 Grant to Study Anti-Depressive Effects of Enriched Environments Early in Life

Dr. Kazuko Sakata

Dr. Kazuko Sakata

An enriched environment that includes exercise, social interaction and mental stimulation has been proven to help prevent or reverse depression. But it’s not clear exactly when in life an enriched environment has the most anti-depressive effect. [Read more...]

UTHSC Assistant Professor Adebowale Adebiyi Receives $1.5 Million Grant for Kidney Function Research

A newly funded NIH grant will allow Dr. Adebowale Adebiyi to further investigate newborn kidney function.  He will focus on the functions of cell membrane proteins known as “ion channels” that are located in blood vessels and glomeruli (delicate units where blood is cleaned and filtered) within the kidneys.

A newly funded NIH grant will allow Dr. Adebowale Adebiyi to further investigate newborn kidney function. He will focus on the functions of cell membrane proteins known as “ion channels” that are located in blood vessels and glomeruli (delicate units where blood is cleaned and filtered) within the kidneys.

Adebowale AdebiyiPhD, assistant professor in the Department of Physiology at the University of Tennessee Health Science Center (UTHSC), has received a grant totaling $1.5 million from the National Institute of Diabetes and Digestive and Kidney Diseases, a subsidiary of the National Institutes of Health. The award will be used to support a project titled, “Regulation of Neonatal Renal Hemodynamics.” The award will be distributed over a five-year period. [Read more...]

Professor S. Casey Laizure of UTHSC Receives $150,000 Grant for Caffeine Inhalation Research

Dr. S. Casey Laizure holds an Aeroshot™ 100 mg caffeine administration device, an integral part of his NIH-funded study, sold by Breathable Foods, Inc. The study of this device, which dispenses caffeine upon inspiration, will provide insight into caffeine blood levels achieved after inhalation.

Dr. S. Casey Laizure holds an Aeroshot™ 100 mg caffeine administration device, an integral part of his NIH-funded study, sold by Breathable Foods, Inc. The study of this device, which dispenses caffeine upon inspiration, will provide insight into caffeine blood levels achieved after inhalation.

S. Casey Laizure, PharmD, professor in the Department of Clinical Pharmacy, at the University of Tennessee Health Science Center (UTHSC) College of Pharmacy, has received a grant totaling $150,000 from the National Institute on Drug Abuse, a part of the National Institutes of Health. The award will be used to support the study of caffeine disposition in humans after inhalation. [Read more...]

Meibohm Awarded NIH Instrumentation Grant

Bernd Meibohm, PhD, FCP, associate dean for Research and Graduate Programs and professor of Pharmaceutical Sciences at the University of Tennessee Health Science Center (UTHSC) College of Pharmacy has received a shared instrumentation grant in the amount of $315,651 from the National Institutes of Health (NIH). This grant will allow for the acquisition of a triple quadrupole mass spectrometer as shared instrumentation that supports 12 NIH-supported research projects in the University of Tennessee Colleges of Pharmacy and Medicine focused on drug discovery and development. Targeted indications include the treatments of a variety of cancer types, tuberculosis, radiation injury, and other conditions. The requested instrument will be utilized for the quantification of drug candidates and their metabolites in biological samples in support of these research efforts.Meibohm NIH Grant

Laizure and Parker Awarded NIH R03 Grant

Casey Laizure, PharmD and Robert Parker, PharmD, BA, both in the Department of Clinical Pharmacy, received a $150,000 grant from the National Institute on Drug Abuse to study how rapidly caffeine gets into the body after consuming an energy drink or inhaling a caffeine powder.  New types of caffeine fortified supplements can potentially be abused, especially in combination with alcohol. An important determinant of their abuse potential is how fast the caffeine is absorbed into the body. This study will compare the absorption of caffeine from an energy drink to caffeine administered using an Aeroshot™ inhalation device.  Media reports suggest that the Aeroshot™ device results in a “caffeine buzz” that suggests very rapid caffeine absorption.  This will be the first study of caffeine blood levels achieved after using the Aeroshot™ device and is expected to provide information about the abuse potential of this method of caffeine use.

UTHSC’s Bernd Meibohm Receives $315,651 Instrumentation Grant for Small Molecule Drug Development

Bernd Meibohm, PhD, FCP, associate dean for Research and Graduate Programs, and professor in the Department of Pharmaceutical Sciences at the University of Tennessee Health Science Center (UTHSC), has received a grant totaling $315,651 from the Office of the Director of the National Institutes of Health (NIH).

This grant will allow for the purchase of a triple quadrupole mass spectrometer as shared instrumentation for 12 NIH-supported research projects in the University of Tennessee Colleges of Pharmacy and Medicine that are focused on drug discovery and development.

Targeted indications include the treatments of a variety of cancer types, tuberculosis, radiation injury, and other conditions. The instrument will be used to measure concentrations of medications in biological samples.

Professor Andrew Kang, MD, Receives $1.65 Million Grant for Rheumatoid Arthritis Research

Dr. Andrew Kang and his team are researching treatment options for rheumatoid arthritis.

Dr. Andrew Kang and his team are researching treatment options for rheumatoid arthritis.

Andrew Kang, MD, professor in the Division of Connective Tissue Diseases in the College of Medicine, has received a grant totaling $1,650,000 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, an Institute of the National Institutes of Health. The award will be used to support a project titled “20 (OH) Vit D3, T Cells, and Arthritis.” The award will be distributed over a five-year period. [Read more...]